SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66 | -52.2% | 17,777 | -13.1% | 0.00% | – |
| Q2 2023 | $138 | -40.5% | 20,460 | -42.8% | 0.00% | – |
| Q1 2023 | $232 | +31.1% | 35,782 | +71.9% | 0.00% | – |
| Q4 2022 | $177 | -99.8% | 20,810 | +4.1% | 0.00% | – |
| Q3 2022 | $106,000 | +19.1% | 19,985 | -4.4% | 0.00% | – |
| Q2 2022 | $89,000 | +48.3% | 20,897 | +22.2% | 0.00% | – |
| Q1 2022 | $60,000 | – | 17,105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 4,012,903 | $15,168,773 | 7.77% |
| Nextech Invest Ltd. | 1,910,029 | $7,219,910 | 2.19% |
| K2 PRINCIPAL FUND, L.P. | 2,552,062 | $9,646,794 | 2.02% |
| Charles Schwab Trust Co | 4,246,071 | $16,050,148 | 1.81% |
| Sio Capital Management, LLC | 1,105,911 | $4,180,344 | 1.29% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,077,927 | $41,874,564 | 0.92% |
| SECTORAL ASSET MANAGEMENT INC | 1,049,191 | $3,965,942 | 0.77% |
| Orbimed Advisors | 9,240,887 | $34,930,553 | 0.74% |
| RA Capital Management | 9,459,678 | $35,757,583 | 0.70% |
| K2 PRINCIPAL FUND, L.P. | 688,900 | $2,604,042 | 0.55% |